Survivin: a potential marker of resistance to somatostatin receptor ligands.
Clarissa G Borba HerkenhoffEricka B TrarbachRafael Loch BastistaIberê Cauduro SoaresFernando Pereira FrassettoFelipe Barjud Pereira do NascimentoIsabella Pacetti Pajaro GrandePaula P B SilvaFelipe Gaia DuarteMarcello Delano BronsteinRaquel Soares JalladPublished in: The Journal of clinical endocrinology and metabolism (2022)
This study suggests that low survivin expression is predictive of resistance to fg-SRL in somatotropinomas, but not of tumor invasiveness.